First-pass extracted concept

organoids

Candidate: concept label2 source documents3 linked claims

Jump to explainers Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Extracted Explainers

What the tool is doing

The review includes organoids as a 3D model category for dental pulp studies.

Source 1DOI PubMed

Evidence Snippets

from scaffold-based and hydrogel systems to spheroids, organoids, bioprinted constructs, and microfluidic "tooth-on-a-chip" platforms

Evidence 1Source 1DOI PubMedprovenance

Its PubMed abstract states that the review focuses on bioengineered human disease models, especially organoids, bioengineered tissue models, and organs-on-chips, framed around improving clinical translation in drug development.

Evidence 2Source 2DOI PubMedprovenance

Supporting Sources

Source 1primary paper2025MEDDOI PubMed

1 evidence snippet 1 linked claim Claim 1

Source 2review2023Nature Reviews BioengineeringDOI PubMed

1 evidence snippet 2 linked claims Claim 1 Claim 2

Linked Claims

Claim 1review scopesupports2025Source 1DOI PubMed

The source reviews current advances in 3D dental pulp modeling across scaffold-based and hydrogel systems, spheroids, organoids, bioprinted constructs, and microfluidic tooth-on-a-chip platforms.

Claim 2review scopesupports2023Source 2DOI PubMed

The review focuses on bioengineered human disease models, especially organoids, bioengineered tissue models, and organs-on-chips, in the context of drug development and clinical translation.

Claim 3subtype relevancesupports2023Source 2DOI PubMed

Patient-derived organoids are presented in the supplied evidence scaffold as an important translational subtype used for drug screening and response prediction.